A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
A weekly GLP-1 and GIP dual agonist from Roche, the same two receptors as tirzepatide, built to keep the receptors responsive by avoiding one of their shut-off signals. In its 48-week obesity phase 2 trial, the top 24 mg dose took off about 22.5% more weight than placebo, and the curve had not flattened. Commonly reported: in trials, GI side effects, mostly mild to moderate, during the step-ups. It is in phase 3 and not approved anywhere.
With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 4 mg, is 80 units; and the high end, 24 mg, needs more than this vial holds. 2 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.
Enicepatide in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.